BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17056037)

  • 1. Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.
    Osadchii O; Norton G; Deftereos D; Muller D; Woodiwiss A
    Eur J Pharmacol; 2006 Dec; 553(1-3):246-53. PubMed ID: 17056037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin-induced myocardial noradrenergic effects in spontaneously hypertensive rats.
    Osadchii O; Woodiwiss A; Deftereos D; Norton G
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):221-7. PubMed ID: 16495759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle.
    Osadchii O; Norton G; Deftereos D; Badenhorst D; Woodiwiss A
    Eur J Pharmacol; 2005 Sep; 520(1-3):108-17. PubMed ID: 16154127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
    Osadchii O; Woodiwiss A; Alves N; Norton G
    Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.
    Osadchii OE; Woodiwiss AJ; Norton GR
    Pflugers Arch; 2006 May; 452(2):155-63. PubMed ID: 16369769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial structural, contractile and electrophysiological changes in the guinea-pig heart failure model induced by chronic sympathetic activation.
    Soltysinska E; Olesen SP; Osadchii OE
    Exp Physiol; 2011 Jul; 96(7):647-63. PubMed ID: 21571815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
    Osadchii O; Norton G; Woodiwiss A
    Eur J Pharmacol; 2005 May; 514(2-3):201-8. PubMed ID: 15910807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in sensitivity to beta-adrenergic agonist isoproterenol in the isolated adult rat heart following prenatal protein restriction.
    Elmes MJ; Haase A; Gardner DS; Langley-Evans SC
    Br J Nutr; 2009 Mar; 101(5):725-34. PubMed ID: 18590591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.
    Osadchii O; Norton G; Deftereos D; Woodiwiss A
    Pharmacol Res; 2007 Apr; 55(4):287-94. PubMed ID: 17257851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.
    Osadchii OE; Woodiwiss AJ; Deftereos D; Norton GR
    Pflugers Arch; 2007 Nov; 455(2):251-60. PubMed ID: 17558518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
    Deisher TA; Narita H; Zera P; Ginsburg R; Bristow MR; Billingham ME; Fowler MB; Hoffman BB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):262-9. PubMed ID: 8392553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ricin depresses cardiac function in the rabbit heart.
    Ma L; Hsu CH; Patterson E; Thadani U; Robinson CP
    Toxicol Appl Pharmacol; 1996 May; 138(1):72-6. PubMed ID: 8658515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats.
    Lahlou S; Lima GC; Leão-Filho CS; Duarte GP
    Can J Physiol Pharmacol; 2000 Mar; 78(3):260-5. PubMed ID: 10721819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine-induced tachycardia in conscious rats: blunted response following isoproterenol pretreatment for 5 days.
    Lahlou S; Duarte GP
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):165-74. PubMed ID: 9777039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMP-dependent pathway.
    Li HY; Bian JS; Kwan YW; Wong TM
    J Pharmacol Exp Ther; 2000 May; 293(2):592-8. PubMed ID: 10773033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts.
    Silva CO; Monteiro-Filho WO; Duarte GP; Lahlou S
    J Pharm Pharmacol; 2001 Feb; 53(2):233-42. PubMed ID: 11273021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.